Evidence map›Paper›PMID 33742331›Full record

ArticleJournal of digital imaging2021

HER2 Molecular Marker Scoring Using Transfer Learning and Decision Level Fusion.

Suman Tewary, Sudipta Mukhopadhyay

Abstract read
In one paragraph

Article in Journal of digital imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Suman TewarySchool of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
Sudipta MukhopadhyayDepartment of Electronics and Electrical Communication Engineering, Indian Institute of Technology Kharagpur, Kharagpur, India. smukho@ece.iitkgp.ac.in.ORCID 0000-0002-4719-2578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In prognostic evaluation of breast cancer, immunohistochemical (IHC) marker human epidermal growth factor receptor 2 (HER2) is used for prognostic evaluation. Accurate assessment of HER2-stained tissue sample is essential in therapeutic decision making for the patients. In regular clinical settings, expert pathologists assess the HER2-stained tissue slide under microscope for manual scoring based on prior experience. Manual scoring is time consuming, tedious, and often prone to inter-observer variation among group of pathologists. With the recent advancement in the area of computer vision and deep learning, medical image analysis has got significant attention. A number of deep learning architectures have been proposed for classification of different image groups. These networks are also used for transfer learning to classify other image classes. In the presented study, a number of transfer learning architectures are used for HER2 scoring. Five pre-trained architectures viz. VGG16, VGG19, ResNet50, MobileNetV2, and NASNetMobile with decimating the fully connected layers to get 3-class classification have been used for the comparative assessment of the networks as well as further scoring of stained tissue sample image based on statistical voting using mode operator. HER2 Challenge dataset from Warwick University is used in this study. A total of 2130 image patches were extracted to generate the training dataset from 300 training images corresponding to 30 training cases. The output model is then tested on 800 new test image patches from 100 test images acquired from 10 test cases (different from training cases) to report the outcome results. The transfer learning models have shown significant accuracy with VGG19 showing the best accuracy for the test images. The accuracy is found to be 93%, which increases to 98% on the image-based scoring using statistical voting mechanism. The output shows a capable quantification pipeline in automated HER2 score generation.

Indexed as

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesFemaleHumansImmunohistochemistryMachine LearningERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesDeep learningHER2 molecular markerImage analysisImmunohistochemical (IHC) analysisTransfer learning

Identifiers

PMID33742331
PMCPMC8329150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.